您的位置: 首页 > 农业专利 > 详情页

REPROGRAMMING EFFECTOR PROTEIN INTERACTIONS TO CORRECT EPIGENETIC DEFECTS IN CANCER
专利权人:
BRITISH COLUMBIA CANCER AGENCY BRANCH
发明人:
Steven J. M. Jones,Oleksandr Yakovenko,Silvia Thoene,Pierre Yulmin Cheung,Jianghong An
申请号:
US14381588
公开号:
US20150154345A1
申请日:
2013.02.27
申请国别(地区):
US
年份:
2015
代理人:
摘要:
Methods of “reprogramming” epigenetic mark readers or erasers to recognize epigenetic marks other than their cognate (or natural) marks are provided. Reprogramming the reader or eraser can offset the effects of aberrant writer activity (for example, loss of function or overactivity) that can contribute to certain diseases states, such as cancer. The use of the reprogramming compounds identified by these methods in the treatment of such disease states is also provided. Exemplary mark readers that can be targeted by these methods include BPTF and CBX2.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充